[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
K Yamaguchi(Toho University), Isamu Nakasone, Miki ISHII, Yoshitsugu Miyazaki(National Institute of Infectious Diseases), J Igari, Kiyoharu Yamanaka, Masahiro Taira, Y Matsudou, Ono J, I Tamaki, Tappei Takada(University of Tokyo Hospital), Shiomi Ishigo, C Itoh, T Yoshida, F Kashitani, Minoru Yasujima, M Kudoh, Morihiro Iwata, Yoko Tazawa, Kiyoshi Negayama, S Miyazaki, J Katoh, Nobuyuki Uehara, Masao Kuwabara, Toyoko Oguri, Toshiharu Hongo, M Kaku, Naoaki Watanabe(Jikei University School of Medicine), Tadao Funato, S Toyoshima, Hiromi Tashiro, Y Tsujio, T Nisawataira, Yoshimasa Saito, Chizuko Kawamura, Tomohiro Matsushima, Naru Sato(The University of Tokyo), Naoyuki Miyashita(Kawasaki Medical School), Keiichi Nakagawa(University of Tokyo Hospital), Junichi Okada, N Murakami, S Kamihira(Shimane Prefectural Central Hospital), Mitsuomi Kaimori, Y Niki, Yoshitsugu Iinuma, Masahide Takii, Makoto Kanda, Satoshi Kawahara, K. Ueno, Kota Ishii
PubMed
June 1, 2000
Cited by 16
Related Papers
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|438
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria
|Nature Immunology|2011|348
Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes
|Annals of the Rheumatic Diseases|2015|185
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|177